ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 107

$1.52M Total Retail Price of All Prescriptions

Rank: 3 out of 107

418 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

10% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 25,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 973 958 1 5
FUROSEMIDE 893 893 2 3
SIMVASTATIN 761 753 3 2
METOPROLOL TARTRATE 670 658 4 7
LISINOPRIL 656 643 5 4
ISOSORBIDE MONONITRATE ER 548 548 6 30
DONEPEZIL HCL 546 546 7 10
GABAPENTIN 495 481 8 11
LEVOTHYROXINE SODIUM 479 467 9 1
OMEPRAZOLE 473 458 10 6
PLAVIX 402 402 11 43
CARVEDILOL 382 382 12 25
JANUVIA 372 354 13 71
ZOLPIDEM TARTRATE 361 361 14 38
MIRTAZAPINE 340 337 15 16
METFORMIN HCL 338 323 16 13
MECLIZINE HCL 334 334 17 142
CLOPIDOGREL 331 330 18 29
WARFARIN SODIUM 322 322 19 8
ALENDRONATE SODIUM 304 304 20 35
LOVAZA 277 277 21 138
DIOVAN 275 275 22 33
NAMENDA 271 271 23 19
VOLTAREN 263 261 24 172
METOPROLOL SUCCINATE 255 254 25 15
ATENOLOL 239 239 26 21
CRESTOR 231 219 27 63
ATORVASTATIN CALCIUM 230 226 28 17
POTASSIUM CHLORIDE 228 228 29 18
HYDRALAZINE HCL 225 225 30 58
HYDROCHLOROTHIAZIDE 212 212 31 14
LIDODERM 210 210 32 77
FLUTICASONE PROPIONATE 209 209 33 54
NEXIUM 207 206 34 61
CITALOPRAM HBR 202 190 35 9
ALLOPURINOL 198 198 36 48
TAMSULOSIN HCL 194 194 37 27
LOVASTATIN 193 188 38 51
SPIRONOLACTONE 185 185 39 74
LOSARTAN POTASSIUM 180 175 40 36
CLONIDINE HCL 171 171 41 95
ZETIA 165 161 42 126
PROCTOZONE-HC 163 163 43 223
LIPITOR 149 149 44 132
LOSARTAN-HYDROCHLOROTHIAZIDE 148 143 45 154
CREON 147 135 46 273
NAPROXEN 146 133 47 153
SERTRALINE HCL 142 142 48 12
DIGOXIN 137 137 49 37
LACTULOSE 137 137 49 114
FAMOTIDINE 135 135 51 42
CLOTRIMAZOLE-BETAMETHASONE 131 119 52 129
ESCITALOPRAM OXALATE 129 127 53 40
PANTOPRAZOLE SODIUM 123 123 54 28
BUMETANIDE 121 121 55 77
OXYCODONE-ACETAMINOPHEN 120 117 S2 56 53
DIOVAN HCT 116 116 57 137
GEMFIBROZIL 115 103 58 166
ADVAIR DISKUS 114 114 59 47
ACETAMINOPHEN-CODEINE 110 110 S3 60 98
PAROXETINE HCL 108 104 61 80
CELEBREX 107 105 62 82
VESICARE 106 106 63 140
DICYCLOMINE HCL 104 104 64 235
SPIRIVA 99 99 65 69
GLIMEPIRIDE 98 95 66 84
AMLODIPINE BESYLATE-BENAZEPRIL 98 94 66 130
RANITIDINE HCL 97 97 68 41
SYNTHROID 97 97 68 85
PREDNISONE 95 95 70 39
AMIODARONE HCL 93 93 71 93
IPRATROPIUM BROMIDE 86 86 72 147
COMBIVENT 86 86 72 214
TRAMADOL HCL-ACETAMINOPHEN 84 84 74 282
MIDODRINE HCL 84 84 74 234
TRAMADOL HCL 83 83 76 23
NITROSTAT 82 82 77 258
FEXOFENADINE HCL 80 80 78 276
CYMBALTA 79 79 79 52
GLIPIZIDE 77 66 80 46
POLYETHYLENE GLYCOL 3350 76 76 81 24
IBANDRONATE SODIUM 76 76 81 335
DEXILANT 76 76 81 335
SINGULAIR 75 74 84 127
PEN NEEDLE 73 60 85 160
BONIVA 73 73 85 344
ALCOHOL PREP PADS 73 72 85 344
PROAIR HFA 72 72 88 208
CIPROFLOXACIN HCL 72 72 88 73
CLONIDINE 72 70 88 227
FENTANYL 71 71 S2 91 50
FLECTOR 69 69 92 349
INSULIN SYRINGE 68 68 93 162
SINGLE USE SWAB 67 67 94 355
LANTUS SOLOSTAR 66 53 95 111
ATELVIA 65 65 96 360
LYRICA 63 63 97 139
DILTIAZEM 24HR CD 63 62 97 89
ENDOCET 61 61 S2 99 156
OLANZAPINE 61 61 99 57
LEVETIRACETAM 61 61 99 44
TRAZODONE HCL 60 59 102 22
AVODART 58 58 103 248
AMITIZA 58 58 103 169
PRANDIN 58 58 103 170
SANTYL 56 56 106 113
LEXAPRO 56 56 106 163
GLIPIZIDE XL 55 54 108 194
IBUPROFEN 55 55 108 90
COLCRYS 54 53 110 189
QUETIAPINE FUMARATE 54 54 110 31
PRAVASTATIN SODIUM 53 53 112 32
GLIPIZIDE ER 53 53 112 155
FINASTERIDE 53 53 112 72
BENICAR HCT 52 52 115 392
COUMADIN 52 52 115 189
CYCLOBENZAPRINE HCL 52 52 R 115 128
FENOFIBRATE 52 52 115 177
CARBIDOPA-LEVODOPA 51 51 119 56
VYTORIN 51 50 119 294
KLOR-CON 10 51 51 119 259
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.